Nanoparticles as drug delivery system against tuberculosis in zebrafish embryos: Direct visualization and treatment

ACS Nano

Volumn 8, Issue 7, 2014, Pages 7014-7026

  Fenaroli, Federico ^a   Westmoreland, David ^a   Benjaminsen, Jørgen ^a   Kolstad, Terje ^a   Skjeldal, Frode Miltzow ^a   Meijer, Annemarie H ^b   Van Der Vaart, Michiel ^b   Ulanova, Lilia ^a   Roos, Norbert ^a   Nyström, Bo ^a   Hildahl, Jon ^a   Griffiths, Gareth ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

drug delivery; fish tuberculosis; fluorescent imaging; PLGA nanoparticles; zebrafish

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; DRUG DELIVERY; ENDOTHELIAL CELLS; FISH; MACROPHAGES; MAMMALS; NANOPARTICLES;

DRUG DELIVERY SYSTEM; FLUORESCENCE ANALYSIS; FLUORESCENT IMAGING; INTRAVENOUS INJECTIONS; MYCOBACTERIUM TUBERCULOSIS; PLGA NANOPARTICLES; SIMULTANEOUS IMAGING; ZEBRAFISH;

FLUORESCENCE;

ANTIINFECTIVE AGENT; COUMARIN 6; COUMARIN DERIVATIVE; DRUG CARRIER; LACTIC ACID; NANOPARTICLE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; RHODAMINE; RHODAMINE 800; RIFAMPICIN; THIAZOLE DERIVATIVE;

ANIMAL; ANIMAL EMBRYO; CHEMISTRY; DRUG EFFECTS; EMBRYOLOGY; FLUORESCENCE IMAGING; GRANULOMA; MACROPHAGE; METABOLISM; MICROBIOLOGY; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; MYCOBACTERIUM MARINUM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL; TUBERCULOSIS; VETERINARY; ZEBRA FISH;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOLOGICAL TRANSPORT; COUMARINS; DRUG CARRIERS; EMBRYO, NONMAMMALIAN; GRANULOMA; LACTIC ACID; MACROPHAGES; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; MYCOBACTERIUM MARINUM; NANOPARTICLES; OPTICAL IMAGING; POLYGLYCOLIC ACID; RHODAMINES; RIFAMPIN; THIAZOLES; TUBERCULOSIS; ZEBRAFISH;

EID: 84904739202     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn5019126     Document Type: Article

References (52)

1. Russell, D. G. Who Puts the Tubercle in Tuberculosis? Nat. Rev. Microbiol. 2007, 5, 39-47
2. Flynn, J. L.; Chan, J.; Lin, P. L. Macrophages and Control of Granulomatous Inflammation in Tuberculosis Mucosal Immunol. 2011, 4, 271-278
3. Young, D. B.; Perkins, M. D.; Duncan, K.; Barry, C. E., III. Confronting the Scientific Obstacles to Global Control of Tuberculosis J. Clin. Invest. 2008, 118, 1255-1265
4. Zumla, A.; Nahid, P.; Cole, S. T. Advances in the Development of New Tuberculosis Drugs and Treatment Regimens Nat. Rev. Drug Discovery 2013, 12, 388-404
5. Desjardins, M.; Griffiths, G. Phagocytosis: Latex Leads the Way Curr. Opin. Cell. Biol. 2003, 15, 498-503
6. Wattendorf, U.; Merkle, H. P. PEGylation as a Tool for the Biomedical Engineering of Surface Modified Microparticles J. Pharm. Sci. 2008, 97, 4655-4669
7. Russell, D. G. Mycobacterium tuberculosis and the Intimate Discourse of a Chronic Infection Immunol. Rev. 2011, 240, 252-268
8. Griffiths, G.; Nystrom, B.; Sable, S. B.; Khuller, G. K. Nanobead-Based Interventions for the Treatment and Prevention of Tuberculosis Nat. Rev. Microbiol. 2010, 8, 827-834
9. Ranjita, S.; Loaye, A.; Khalil, M. Present Status of Nanoparticle Research for Treatment of Tuberculosis J. Pharm. Pharm. Sci. 2011, 14, 100-116
10. Sosnik, A.; Carcaboso, A. M.; Glisoni, R. J.; Moretton, M. A.; Chiappetta, D. A. New Old Challenges in Tuberculosis: Potentially Effective Nanotechnologies in Drug Delivery Adv. Drug Delivery Rev. 2010, 62, 547-559
11. Pandey, R.; Khuller, G. K. Polymer Based Drug Delivery Systems for Mycobacterial Infections Curr. Drug Delivery 2004, 1, 195-201
12. Kalluru, R.; Fenaroli, F.; Westmoreland, D.; Ulanova, L.; Maleki, A.; Roos, N.; Paulsen Madsen, M.; Koster, G.; Egge-Jacobsen, W.; Wilson, S. et al. Poly(lactide- co -glycolide)-Rifampicin Nanoparticles Efficiently Clear Mycobacterium Bovis Bcg Infection in Macrophages and Remain Membrane-Bound in Phago-lysosomes J. Cell Sci. 2013, 126, 3043-3054
13. Davis, J. M.; Clay, H.; Lewis, J. L.; Ghori, N.; Herbomel, P.; Ramakrishnan, L. Real-Time Visualization of Mycobacterium-Macrophage Interactions Leading to Initiation of Granuloma Formation in Zebrafish Embryos Immunity 2002, 17, 693-702
14. Ramakrishnan, L. Looking within the Zebrafish To Understand the Tuberculous Granuloma Adv. Exp. Med. Biol. 2013, 783, 251-266
15. Meijer, A. H.; Spaink, H. P. Host-Pathogen Interactions Made Transparent with the Zebrafish Model Curr. Drug Targets 2011, 12, 1000-1017
16. Lesley, R.; Ramakrishnan, L. Insights into Early Mycobacterial Pathogenesis from the Zebrafish Curr. Opin. Microbiol. 2008, 11, 277-283
17. Clay, H.; Davis, J. M.; Beery, D.; Huttenlocher, A.; Lyons, S. E.; Ramakrishnan, L. Dichotomous Role of the Macrophage in Early Mycobacterium Marinum Infection of the Zebrafish Cell Host Microbe 2007, 2, 29-39
18. Ellett, F.; Pase, L.; Hayman, J. W.; Andrianopoulos, A.; Lieschke, G. J. Mpeg1 Promoter Transgenes Direct Macrophage-Lineage Expression in Zebrafish Blood 2011, 117, e49-e56
19. Hall, C.; Flores, M. V.; Storm, T.; Crosier, K.; Crosier, P. The Zebrafish Lysozyme C Promoter Drives Myeloid-Specific Expression in Transgenic Fish BMC Dev. Biol. 2007, 7, 42
20. Cui, C.; Benard, E. L.; Kanwal, Z.; Stockhammer, O. W.; van der Vaart, M.; Zakrzewska, A.; Spaink, H. P.; Meijer, A. H. Infectious Disease Modeling and Innate Immune Function in Zebrafish Embryos. In The Zebrafish: Disease Models and Chemical Screens, 3rd ed.; Detrich, H. W.; Westerfield, M.; Zon, L. I., Eds.; Elsevier: Oxford, UK, 2011; Vol. 105, pp 273-308.
21. Lawson, N. D.; Weinstein, B. M. In Vivo Imaging of Embryonic Vascular Development Using Transgenic Zebrafish Dev. Biol. 2002, 248, 307-318
22. Hunter, R. L.; Jagannath, C.; Actor, J. K. Pathology of Postprimary Tuberculosis in Humans and Mice: Contradiction of Long-Held Beliefs Tuberculosis 2007, 87, 267-278
23. Peyron, P.; Vaubourgeix, J.; Poquet, Y.; Levillain, F.; Botanch, C.; Bardou, F.; Daffe, M.; Emile, J. F.; Marchou, B.; Cardona, P. J. et al. Foamy Macrophages from Tuberculous Patients' Granulomas Constitute a Nutrient-Rich Reservoir for M. tuberculosis Persistence PLoS Pathog 2008, 4, e1000204
24. Russell, D. G.; Cardona, P. J.; Kim, M. J.; Allain, S.; Altare, F. Foamy Macrophages and the Progression of the Human Tuberculosis Granuloma Nat. Immunol. 2009, 10, 943-948
25. Daniel, J.; Maamar, H.; Deb, C.; Sirakova, T. D.; Kolattukudy, P. E. Mycobacterium tuberculosis Uses Host Triacylglycerol to Accumulate Lipid Droplets and Acquires a Dormancy-like Phenotype in Lipid-Loaded Macrophages PLoS Pathog. 2011, 7, e1002093
26. Stehr, M.; Elamin, A. A.; Singh, M. Cytosolic Lipid Inclusions Formed during Infection by Viral and Bacterial Pathogens Microbes Infect. 2012, 14, 1227-1237
27. Ward, S. K.; Heintz, J. A.; Albrecht, R. M.; Talaat, A. M. Single-Cell Elemental Analysis of Bacteria: Quantitative Analysis of Polyphosphates in Mycobacterium Tuberculosis Front. Cell. Infect. Microbiol. 2012, 2, 63
28. Lowery, L. A.; Sive, H. Initial Formation of Zebrafish Brain Ventricles Occurs Independently of Circulation and Requires the Nagie Oko and Snakehead/Atp1a1a.1 Gene Products Development 2005, 132, 2057-2067
29. Benard, E. L.; van der Sar, A. M.; Ellett, F.; Lieschke, G. J.; Spaink, H. P.; Meijer, A. H. Infection of Zebrafish Embryos with Intracellular Bacterial Pathogens J. Vis. Exp. 2012, e3781
30. Davis, J. M.; Ramakrishnan, L. The Role of the Granuloma in Expansion and Dissemination of Early Tuberculous Infection Cell 2009, 136, 37-49
31. Sharma, A.; Sharma, S.; Khuller, G. K. Lectin-Functionalized Poly(lactide- co -glycolide) Nanoparticles as Oral/Aerosolized Antitubercular Drug Carriers for Treatment of Tuberculosis J. Antimicrob. Chemother. 2004, 54, 761-766
32. Adams, K. N.; Takaki, K.; Connolly, L. E.; Wiedenhoft, H.; Winglee, K.; Humbert, O.; Edelstein, P. H.; Cosma, C. L.; Ramakrishnan, L. Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism Cell 2011, 145, 39-53
33. Stoop, E. J.; Schipper, T.; Huber, S. K.; Nezhinsky, A. E.; Verbeek, F. J.; Gurcha, S. S.; Besra, G. S.; Vandenbroucke-Grauls, C. M.; Bitter, W.; van der Sar, A. M. Zebrafish Embryo Screen for Mycobacterial Genes Involved in the Initiation of Granuloma Formation Reveals a Newly Identified Esx-1 Component Dis. Models & Mech. 2011, 4, 526-536
34. Swaim, L. E.; Connolly, L. E.; Volkman, H. E.; Humbert, O.; Born, D. E.; Ramakrishnan, L. Mycobacterium Marinum Infection of Adult Zebrafish Causes Caseating Granulomatous Tuberculosis and Is Moderated by Adaptive Immunity Infect. Immun. 2006, 74, 6108-6117
35. Ramakrishnan, L. Revisiting the Role of the Granuloma in Tuberculosis Nat. Rev. Immunol. 2012, 12, 352-366
36. Volkman, H. E.; Clay, H.; Beery, D.; Chang, J. C. W.; Sherman, D. R.; Ramakrishnan, L. Tuberculous Granuloma Formation Is Enhanced by a Mycobacterium Virulence Determinant PLoS Biol. 2004, 2, 1946-1956
37. Volkman, H. E.; Pozos, T. C.; Zheng, J.; Davis, J. M.; Rawls, J. F.; Ramakrishnan, L. Tuberculous Granuloma Induction via Interaction of a Bacterial Secreted Protein with Host Epithelium Science 2010, 327, 466-469
38. Hunter, R. L. Pathology of Post Primary Tuberculosis of the Lung: An Illustrated Critical Review Tuberculosis 2011, 91, 497-509
39. Hoff, D. R.; Ryan, G. J.; Driver, E. R.; Ssemakulu, C. C.; De Groote, M. A.; Basaraba, R. J.; Lenaerts, A. J. Location of Intra- and Extracellular M. tuberculosis Populations in Lungs of Mice and Guinea Pigs during Disease Progression and after Drug Treatment PLoS One 2011, 6, e17550
40. Sharma, S. K.; Mohan, A.; Sharma, A. Challenges in the Diagnosis & Treatment of Miliary Tuberculosis Indian J. Med. Res. 2012, 135, 703-730
41. Myers, J. N. Miliary, Central Nervous System, and Genitourinary Tuberculosis DM, Dis.-Mon. 2007, 53, 22-31
42. Ray, S.; Talukdar, A.; Kundu, S.; Khanra, D.; Sonthalia, N. Diagnosis and Management of Miliary Tuberculosis: Current State and Future Perspectives Ther. Clin. Risk Manage. 2013, 9, 9-26
43. Sharma, P. K.; Saha, P. K.; Singh, A.; Sharma, S. K.; Ghosh, B.; Mitra, D. K. Foxp3+ Regulatory T Cells Suppress Effector T-Cell Function at Pathologic Site in Miliary Tuberculosis Am. J. Respir. Crit. Care Med. 2009, 179, 1061-1070
44. Sharma, S. K.; Mitra, D. K.; Balamurugan, A.; Pandey, R. M.; Mehra, N. K. Cytokine Polarization in Miliary and Pleural Tuberculosis J. Clin. Immunol. 2002, 22, 345-352
45. Mohammad, A. K.; Reineke, J. J. Quantitative Detection of PLGA Nanoparticle Degradation in Tissues Following Intravenous Administration Mol. Pharm. 2013, 10, 2183-2189
46. Dannenberg, A. M. Macrophage Turnover, Division and Activation within Developing, Peak and "Healed" Tuberculous Lesions Produced in Rabbits by Bcg Tuberculosis 2003, 83, 251-260
47. Kolhar, P.; Anselmo, A. C.; Gupta, V.; Pant, K.; Prabhakarpandian, B.; Ruoslahti, E.; Mitragotri, S. Using Shape Effects To Target Antibody-Coated Nanoparticles to Lung and Brain Endothelium Proc. Natl. Acad. Sci. U.S.A. 2013, 110, 10753-10758
48. Smith, J. P. Nanoparticle Delivery of Anti-Tuberculosis Chemotherapy as a Potential Mediator against Drug-Resistant Tuberculosis Yale J. Biol. Med. 2011, 84, 361-369
49. Kisich, K. O.; Gelperina, S.; Higgins, M. P.; Wilson, S.; Shipulo, E.; Oganesyan, E.; Heifets, L. Encapsulation of Moxifloxacin within Poly(butyl cyanoacrylate) Nanoparticles Enhances Efficacy against Intracellular Mycobacterium tuberculosis Int. J. Pharm. 2007, 345, 154-162
50. Hwang, S. M.; Kim, D. D.; Chung, S. J.; Shim, C. K. Delivery of Ofloxacin to the Lung and Alveolar Macrophages via Hyaluronan Microspheres for the Treatment of Tuberculosis J. Controlled Release 2008, 129, 100-106
51. Giovagnoli, S.; Blasi, P.; Schoubben, A.; Rossi, C.; Ricci, M. Preparation of Large Porous Biodegradable Microspheres by Using a Simple Double-Emulsion Method for Capreomycin Sulfate Pulmonary Delivery Int. J. Pharm. 2007, 333, 103-111
52. Gao, L. Y.; Manoranjan, J. Laboratory Maintenance of Mycobacterium Marinum. Current Protocols in Microbiology; Wiley: New York, 2005; Chapter 10, Unit 10B.11.